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Objectives. This study sought to define 1) the risk of sudden
death after operation for common congenital heart defects; and 2)
factors associated with an increased risk of sudden death.
Background. Although the prognosis for patients with congen-
ital heart defects is improved by surgical treatment, they remain
at a well recognized but poorly defined risk of late sudden death.
Methods. This population-based study evaluated all patients
<19 years old undergoing surgical treatment of common forms of
congenital heart disease in the state of Oregon between 1958 and
1996. Patients were identified retrospectively through 1958, with
prospective biannual follow-up beginning in 1982. The incidence
and cause of late sudden death were evaluated for 3,589 patients
surviving operation for the following defects: atrial, ventricular
and atrioventricular septal defects; patent ductus arteriosus;
pulmonary stenosis; aortic stenosis; coarctation of the aorta;
tetralogy of Fallot; and D-transposition of the great arteries.
Results. There were 41 unexpected late sudden deaths during
45,857 patient-years of follow-up, an overall event rate of 1/1,118
patient-years. Thirty-seven of the 41 late sudden deaths occurred
in patients with aortic stenosis, coarctation, transposition of the
great arteries or tetralogy of Fallot, an event rate of 1/454
patients-years. In contrast, only four sudden deaths occurred
among the other defects, an event rate of 1/7,154 patient-years
(p < 0.01). The risk of late sudden death increased incrementally
20 years after operation for tetralogy of Fallot, aortic stenosis and
coarctation. However, risk was not dependent on patient age at
operation or surgical era. The causes of sudden death were
arrhythmia in 30 patients, circulatory (embolic or aneurysm
rupture) in 7 and acute heart failure in 4.
Conclusions. The risk of late sudden death for patients surviv-
ing operation for common congenital heart defects is 25 to 100
times greater than an age-matched control population. This
increased risk is primarily represented by patients with cyanotic
or left heart obstructive lesions. The risk of sudden death appears
to be time dependent, increasing primarily after the second
postoperative decade.
(J Am Coll Cardiol 1998;32:245–51)
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Surgical treatment has significantly improved the short- and
midterm prognosis of patients with congenital heart disease.
However, as the population of long-term survivors increases,
unexpected late sudden death due to cardiovascular causes is
increasingly recognized as a potential hazard after ostensibly
corrective cardiac operations (1–6).
At least 20 factors have been proposed as predictive of an
increased risk of late sudden death in these patients, with most
studies focusing on previous surgical repair of tetralogy of
Fallot (TOF) (7). The heterogeneity of these risk factors
reflects uncertainties regarding the causes and mechanisms of
sudden death in patients after surgical treatment of congenital
heart disease and the relatively low incidence of sudden death
among these patients during short-term follow-up. Further-
more, it is uncertain whether risk factors proposed for patients
with TOF are relevant to postoperative patients with other
forms of congenital heart disease.
This study of sudden cardiac death (SCD) is part of a
prospective population-based study of patients who have un-
dergone surgical treatment of congenital heart disease. The
overall 25-year survival of this cohort has been the subject of
another report (8). The purpose of the present study was to
specifically evaluate the risk of SCD during long-term
follow-up after surgical treatment of congenital heart disease.
Secondary objectives were to compare the relative risks and
causes of sudden death among the various heart defects and
determine whether objective factors could be identified that
predicted an increased association with late sudden death.
Methods
Patients. The study evaluated all Oregon residents under-
going surgical treatment of congenital heart disease between
1958 and 1996. Patient inclusion criteria were age ,19 years at
initial operation and survival .30 days after operation. During
the study interval, 99.5% of operations for congenital heart
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disease were performed at five hospitals in Oregon, with 0.5%
of operations performed in another state.
A registry of all patients with congenital heart disease was
initially established in 1982, with retrospective identification of
all patients undergoing surgical treatment of congenital heart
disease since 1958. Patient accrual has been prospective since
that time. After establishment of the registry, biannual
follow-up has been determined by clinical evaluation, tele-
phone interview or mailed questionnaire. If no response was
obtained, the National Death Index was reviewed for identifi-
cation of missing patients. Patients in whom earlier follow-up
had been obtained, but whose status was not determined in the
most recent data cycle, were included in analysis up to the time
of most recent follow-up. The most recent data cycle was
completed in 1996.
For the purposes of this study, patients with the following
congenital heart defects were evaluated: secundum atrial sep-
tal defect, ventricular septal defect, atrioventricular (AV)
septal defect (including primum atrial septal defect), patent
ductus arteriosus, pulmonary stenosis, aortic valve stenosis
(AS), coarctation of the aorta (CoA), TOF and D-transposition
of the great arteries (D-TGA). These defects were selected
because they represent all defects that would allow at least 20
years of postsurgical follow-up and adequate numbers to
permit inferential statistical analysis. Patients with complex
forms of these defects, such as AV septal defect with TOF or
D-TGA with right ventricular hypoplasia were excluded from
this analysis.
Definitions. SCD was defined as acute cardiovascular col-
lapse from which biologic death occurred or from which the
patient never regained consciousness. The mechanisms of
death were classified according to modification of criteria
proposed by the Cardiac Arrhythmia Pilot Study (9): 1) sudden
arrhythmic (proven or presumed); 2) sudden nonarrhythmic
(i.e., embolism or aneurysm rupture); 3) nonsudden cardiac
death (i.e., reoperation or congestive heart failure); and 4)
noncardiac (i.e., trauma, malignancy). Patients with non-
sudden cardiac death or noncardiac causes of death were
included in the cohort until the time of death.
Statistical analysis. The statistical methods for this analy-
sis have been previously reported in detail (8). Survival was
estimated by the Kaplan-Meier method, defined as the elapsed
time from the date of operation to date of death or last known
follow-up. The Mantel-Cox statistic was used for comparison
of survival between groups of patients.
Results
Patients. According to the aforementioned inclusion crite-
ria, a total of 3,589 patients were identified, from whom a total
follow-up of 45,857 patient-years was derived. The distribution
of the individual forms of congenital heart disease and
follow-up are shown in Table 1. In this registry, 91.5% of
patients are non-Hispanic white, 2.4% Asian, 3.2% Hispanic,
2.1% African-American and 0.8% native-American. The gen-
der distribution differs markedly by defect on the basis of
natural occurrence; the groups with TOF, D-TGA, AS and
CoA are predominately male, whereas those with an atrial or
AV septal defect or patent ductus arteriosus are predominately
female. Follow-up for survival through 1994 (the beginning of
the last completed data cycle) was completed in 90% of the
Abbreviations and Acronyms
AS 5 aortic stenosis
AV 5 atrioventricular
CoA 5 coarctation of the aorta
SCD 5 sudden cardiac death
D-TGA 5 D-transposition of the great arteries
TOF 5 tetralogy of Fallot
Table 1. Specific Congenital Heart Defects and Incidence of Sudden and Nonsudden Cardiac Death
No. (%) of Pts
With Complete
Follow-Up
Total
Follow-Up
(pt-yr)
Sudden Cardiac Death
Nonsudden Cardiac
Death
No.
Incidence/
1,000 Pt-yr No.
Incidence/
1,000 Pt-yr
ASD 622 (86%) 7,904 0 0 0 0
VSD 527 (87%) 6,354 1 0.2 8 1.2
AVSD 254 (87%) 2,217 2 0.9 15 6.7
PDA 623 (82%) 8,753 0 0 4 0.4
PS 241 (91%) 3,568 1 0.3 2 0.6
AS 169 (94%) 1,860 10 5.4 9 4.8
CoA 536 (92%) 6,706 9 1.3 17 2.5
TOF 445 (91%) 7,082 11 1.5 9 1.3
D-TGA 172 (95%) 1,413 7 4.9 10 6.9
Total 3,589 45,857 41 0.9 74 1.6
AS 5 aortic stenosis; ASD 5 atrial septal defect; AVSD 5 atrioventricular septal defect; CoA 5 coarctation of the
aorta; PDA 5 patent ductus arteriosus; PS 5 pulmonary stenosis; pt-yr 5 patient-years; Pts 5 patients; D-TGA 5
dextro-transposition of the great arteries; TOF 5 tetralogy of Fallot; VSD 5 ventricular septal defect.
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entire cohort, ranging from 82% in patients with a patent
ductus arteriosus to 95% in patients with D-TGA.
Events. There were a total of 41 sudden, unexpected late
deaths during the 45,857 patient-years, for an event rate of
0.9/1,000 patient-years, or 1 event/1,118 patient-years. Thirty-
seven of the 41 late SCDs occurred in patients with four
defects: TOF (n 5 11), D-TGA (n 5 7), CoA (n 5 9) and AS
(n 5 10). The cumulative event rate for patients with these
four defects was 1/454 patient-years, or 2.2 events/1,000 patient
years. In comparison, the SCD event rate for patients with left
to right shunt lesions or pulmonary stenosis was 1/7,154 patient
years, or 0.14/1,000 patient years (p , 0.001). The observed
incidence of sudden death ranged from 0 in patients with an
atrial septal defect or patent ductus to ;5/1,000 patient-years
for patients with AS or D-TGA (Table 1). During this study
period, 74 other patients died of non–sudden cardiac causes
(reoperation [n 5 32], chronic congestive heart failure [n 5 22]
and pulmonary hypertension [n 5 20]), whereas 61 patients
died of noncardiac causes.
Mechanisms of unexpected SCD. On the basis of informa-
tion obtained from witnesses, medical or rescue squad reports
and autopsy data, a determination of the actual or probable
cause of SCD was made. The causes of the 41 SCDs were
arrhythmia in 30 patients, circulatory in 7 (embolic in 5,
aneurysm rupture in 2) and acute ventricular failure in 4. The
causes of SCD among specific forms of congenital heart
disease are illustrated in Figure 1.
Of the 30 patients with an arrhythmic cause of SCD, 14 had
ventricular tachycardia or fibrillation documented at time of
attempted resuscitation, whereas 2 had complete AV block
with an agonal idioventricular rhythm. Of the 14 patients with
a presumed arrhythmic cause of SCD, 6 collapsed suddenly
during exertion, and 4 died in their sleep; in 4 patients, the
circumstances at time of cardiovascular collapse were not
clearly recorded.
Temporal analysis of the incidence of SCD. The incidence
of late SCD was evaluated as a function of the duration of
follow-up, both for the entire cohort and for patients with
specific congenital heart defects. For patients with D-TGA, the
risk of late SCD was relatively constant, with the incidence of
SCD estimated at 4 6 7% at 10 years and 9 6 4% at 20 years
of follow-up (mean 6 SEE). In contrast, the incidence of late
sudden death for patients with a previous repair of TOF
increased primarily after 20 years of follow-up. At 20 years of
follow-up, the incidence of SCD was 2 6 1%, increasing to 4 6
1% at 25 years and 6 6 7% at 30 years (Fig. 2).
An apparent time-dependent incremental risk of late SCD
was also observed for patients with left-heart obstructive
lesions. The estimated incidence of late SCD for patients with
AS was 3 6 2% at 10 years of follow-up, increasing to 13 6 5%
at 20 years and 20 6 8% at 30 years. For patients with CoA, the
incidence of SCD was 1 6 0.5% at 20 years of follow-up,
increasing to 5 6 2% at 25 years and 8 6 3% at 30 years (Fig.
3). Two of the nine patients with CoA who died suddenly had
undergone subsequent operation for AS at 14 and 15 years
after their initial operation, respectively. However, because the
index surgical procedure for entry into this study was for CoA,
these patients were included in the analysis of the cohort with
this defect.
Causes of late SCD. Several observations were made
among the patients who died suddenly: 1) of the seven patients
with D-TGA who died suddenly, five were participating in
Figure 1. Documented or probable etiologies of death among the 41
patients who died suddenly (arrhythmia [hatched bars], circulatory
[open bars], congestive heart failure [solid bars]). The anatomic
diagnoses of the other patients were pulmonary stenosis in one patient,
ventricular septal defect in one and AV septal defect in two.
Figure 2. Actuarial probability of SCD-free survival after surgical
treatment of cyanotic congenital heart defects.
Figure 3. Actuarial probability of SCD-free survival after surgical
treatment of left heart obstructive lesions.
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active physical exertion at the time of death. Polymorphic
ventricular tachycardia or fibrillation was the terminal cardiac
rhythm in the four patients with D-TGA for whom electrocar-
diographic documentation was available. Six of these patients
had undergone a previous Mustard procedure, whereas an
arterial switch procedure had been performed in the other
patient. 2) Profound ventricular hypertrophy was a notable
finding among several of the patients with CoA who died
suddenly. 3) Agonal bradycardia due to advanced AV block
was the initial documented rhythm in two patients with TOF.
Both patients had transient postoperative AV block and
residual bifascicular block. 4) The etiologies of sudden death
were diverse among patients with valvular AS. Significant
residual valvular stenosis or insufficiency was present in three
of four patients with arrhythmic SCD. Four patients died of
cerebral or coronary embolic complications, associated with
aortic valve endocarditis in two, whereas two patients died of
low cardiac output secondary to acute ventricular failure.
Secondary risk factor analysis. The possible associations
between surgical era and patient age at definitive operation
and the occurrence of late SCD were evaluated. The risk of
late SCD as a function of surgical era was considered a
comparison of patients undergoing operation before 1980 with
those operated on in 1980 and later. This time frame was
chosen because these intervals would allow comparable
follow-up of patients with up to 15 years of follow-up data
during both periods. This analysis was restricted to patients
with TOF, CoA and AS because of the limited number of SCD
events among patients with other forms of CHD and because
the surgical techniques for D-TGA have evolved from the
Mustard and Senning atrial switch procedures to arterial
switch methods during the past decades. There was no ob-
served difference in the incidence of late SCD for the three
aforementioned defects through 15 years of follow-up, whether
operated on before 1980 or later (Table 2). However, these
data do not reflect the significant reductions in the perioper-
ative deaths that have occurred over the decades.
Age at primary operation was the second variable that was
evaluated in relation to the risk of late SCD. This analysis
compared patients undergoing surgical repair of their congen-
ital heart disease at age ,2 years compared with those
undergoing operation at $2 years of age. Analysis for the risk
of late SCD by age at operation was not performed for patients
with D-TGA because the operation was usually performed
within the first 3 months of life. After 15 years of follow-up, no
association was observed between age at operation and inci-
dence of late SCD for any defect (Table 3). Additionally, no
statistically significant association between SCD and either
gender, race or presence of genetic or extracardiac abnormal-
ities was identified.
Discussion
The unexpected SCD of a young person from cardiovascu-
lar disease is a tragic, but fortunately, extremely uncommon
event in the general population. Several population-based
studies (10–12) have evaluated the risk of SCD in young
patients (,20 years old), with the reported incidence between
1/25,000 and 1/100,000 patient-years. The incidence of unex-
pected SCD has also been the subject of study among selected
subpopulations of young patients, particularly young athletes
or patients with known cardiovascular diagnoses, such as
Table 2. Probability of Sudden Death-Free Survival by Surgical Era
and Duration of Follow-Up
Surgical
Era
No. of
Pts
Postoperative Follow-Up Duration
(mean 6 SEE)
5 Years 10 Years 15 Years
TOF
,1980 265 0.99 6 0.01 0.99 6 0.01 0.99 6 0.01
$1980 180 0.99 6 0.01 0.99 6 0.01 0.99 6 0.01
AS
,1980 63 0.98 6 0.02 0.97 6 0.02 0.95 6 0.03
$1980 106 0.97 6 0.02 0.97 6 0.02 0.88 6 0.09
CoA
,1980 236 1.0 0.99 6 0.01 0.99 6 0.01
$1980 300 0.99 6 0.01 0.99 6 0.01 0.99 6 0.01
Abbreviations as in Table 1.
Table 3. Probability of Sudden Death-Free Survival by Age at Operation and Duration of
Postoperative Follow-Up
Age at
Operation (yr)
No. of
Postop
Survivors
Postop Follow-Up Duration (mean 6 SEE)
5 Years 10 Years 15 Years 20 Years 25 Years
TOF
,2 236 0.99 6 0.01 0.99 6 0.01 0.99 6 0.01 0.99 6 0.01 0.95 6 0.04
$2 209 0.98 6 0.01 0.98 6 0.01 0.98 6 0.01 0.97 6 0.01 0.96 6 0.02
AS
,2 59 0.98 6 0.02 0.98 6 0.02 0.98 6 0.02 0.98 6 0.02
$2 110 0.98 6 0.02 0.96 6 0.07 0.93 6 0.03 0.85 6 0.05 0.85 6 0.02
CoA
,2 262 0.98 6 0.01 0.98 6 0.01 0.98 6 0.01 0.98 6 0.01 0.98 6 0.01
$2 274 1.0 0.99 6 0.01 0.99 6 0.01 0.99 6 0.01 0.94 6 0.03
Postop 5 postoperative; other abbreviations as in Table 1.
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Wolff-Parkinson-White syndrome or the congenital long QT
syndromes (13–15). Most of these studies have excluded
patients with previous surgical treatment for congenital heart
disease because of a presumed higher risk of late SCD.
As the general population of patients surviving operation
for congenital heart defects continues to achieve greater
longevity, questions regarding the long-term prognosis for
these patients become increasingly pertinent (16). These in-
clude the relative risk of late SCD among patients with diverse
forms of congenital heart disease, potential identification of
risk factors for late SCD and the requirement for ongoing
medical evaluation decades after ostensibly corrective cardiac
surgery. The purpose of the present study was to address these
issues in a population-based study of patients after operation
for common forms of congenital heart disease, in whom
long-term survival would be anticipated.
Late SCD, years or decades after operation for congenital
heart disease, has been the subject of several reports (1–6).
However, most reports have focused on one specific defect,
such as TOF or D-TGA, in which there is a relatively high
incidence of late SCD (17,18). In contrast, one purpose of the
present population-based study was to evaluate the compara-
tive risk of late SCD among patients with various common
defects, given the long-term follow-up, high rates of patient
follow-up and unbiased population study design.
Factors associated with increased risk of late SCD. The
two principal findings of this study were the marked variance in
the relative risks for late SCD among patients with various
defects and the apparent time-dependent nature of this risk for
certain defects. Overall, the incidence of late SCD in the entire
cohort was 0.9/1,000 patient-years, representing an increased
risk of between 25 and 100 times that for the general popula-
tion. However, the incidence of late SCD of 1/7,154 patient-
years for patients with left to right intracardiac shunt lesions or
pulmonary stenosis approaches that of the general population
(1/25,000 to 100,000 patient years). In contrast, the incidence
of late SCD was markedly increased in patients with left heart
obstructive lesions and cyanotic defects, with the estimated risk
between 50 and 200 times that of the general population. The
marked increase in the incidence of late SCD was primarily
accounted for by patients with AS and D-TGA, in whom the
incidence of late SCD was ;1/200 patient-years.
Late SCD after repair of D-TGA. Further evaluation of the
incidence of SCD for specific defects demonstrated an early
onset and relatively constant risk for patients undergoing the
Mustard or Senning procedures for D-TGA, with estimated
SCD-free survival rates of 96% at 10 years and 91% at 20 years
of postoperative follow-up. The risk of late SCD in patients
with D-TGA in this series is similar to that reported in separate
series by Gewillig et al. (6) and Gelatt et al. (18), although
those two studies primarily evaluated total actuarial survival
rather than late SCD. In those two studies, actuarial total
cardiac death-free survival rates of 67% and 76% at 20 years of
postsurgical follow-up were reported. By comparison, the total
cardiac death-free survival rate for patients in the present
study with D-TGA at 20 years was 71%.
Late SCD after repair of TOF. The incidence and risk
factors for late SCD after operation for TOF have both been
the subject of multiple studies that have involved single
institutions as well as collaborative efforts (1,17,19,20). Al-
though comparison of those studies is limited by differences in
design, definition and length of follow-up, a meta-analysis of 39
studies (21) reported a 1.8% incidence of late SCD among
4,583 patients with an average of 8.3 years of follow-up after
surgical treatment of TOF. This relatively low incidence of
SCD is consistent with the findings of the present study, where
the incidence of late SCD at 10 years of follow-up was 1.2%. A
relatively low incidence of late SCD after surgical treatment of
TOF was also observed in our study during the second
postoperative decade, with a cumulative 20-year actuarial
incidence of late SCD of 2.2%. However, incremental in-
creases in the incidence of SCD to 4% at 25 years and 6% at
30 years of follow-up suggest a time-dependent risk of late
death.
Murphy et al. (22) also reported a 6% incidence of late
SCD among patients with 30 years of follow-up after surgical
treatment of TOF (10 deaths among 163 patients). However,
although identical rates of late SCD during equivalent
follow-up are reported in that (22) and our study, a late or
time-dependent risk for late SCD was not observed by Murphy
et al. In light of the small numbers of events in both series, the
need for cautious interpretation of data would seem prudent.
Conversely, it would seem reasonable to conclude that the
earlier estimates of a 5% to 10% risk of late SCD during
adolescence after repair of TOF have not been substantiated
by long-term follow-up.
Late SCD in patients with AS. The highest incidence of late
SCD in the present series was observed among patients with
AS, with an incidence of 3% at 10 years of follow-up, increas-
ing to 13% at 20 years and 20% at 30 years of follow-up. This
finding is somewhat surprising in view of the paucity of
published data on SCD in young patients with AS. The issue of
late SCD among postsurgical patients with AS was noted by
the Second Natural History Study of Congenital Heart Defects
(23). In that study, there were 19 late unexpected SCDs
(presumably arrhythmic) and 4 deaths from bacterial endocar-
ditis among 240 surgically managed patients. These events
occurred over 15 years of follow-up and represent a nearly
10% incidence of late SCD during this interval. A significant
incidence of arrhythmic SCD was also observed among young
patients with AS in registry data reported for patients who had
undergone implantable cardioverter-defibrillator placement
after resuscitation from sudden cardiac arrest (24). Also, the
risk of late SCD from embolic sequelae of endocarditis may be
an underestimated factor in the evaluation of these patients.
Late SCD after repair of CoA. The finding of late SCD
among patients with CoA was unanticipated because only 1 of
536 survivors died suddenly during the first 20 years of
follow-up. However, recent studies (25) have reported unex-
plained advanced left ventricular hypertrophy in patients with
previous repair of CoA, with the suggestion that the biologic
template for advanced ventricular hypertrophy may be estab-
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lished at a young age, with complete expression only during
early adulthood. This finding emphasizes the need for ongoing
follow-up of these patients despite apparent complete relief of
aortic obstruction at rest. Similar caution and concern are also
warranted for patients after patch aortoplasty repair of CoA,
who require long-term follow-up for both the occurrence and
significance of aortic aneurysm after this procedure (26).
Factors not associated with increased risk of late SCD.
Two additional issues that were examined in our study were
impact of the surgical era on late incidence of SCD and
whether early repair (age ,2 years) was associated with a
lower risk of late SCD. With regard to surgical era (before
1980 vs. 1980 and later), no difference in the incidence of late
SCD was observed for the same defects with equal duration of
follow-up. However, there were distinct differences in the
operative mortalities for the two eras, a subject that has been
addressed previously (8). Additional follow-up of the cohort
through 30 years after operation will be required to determine
whether the trend for increasing rates of mortality over a
longer postoperative interval will be repeated in the group
operated on in the more recent era. However, it would appear
that the duration of postsurgical follow-up rather than the
surgical era may be the critical factor in defining the risk of late
SCD.
With recent advances in surgical techniques, it has been
proposed that early primary repair may reduce the risk of late
SCD (27). However, others have suggested that longer
follow-up will be required to substantiate this observation. The
results of the present study are consistent with the latter
proposal: Decades rather than years of follow-up may be
required to validate a benefit of early primary repair. In our
study, comparison of patients undergoing operation at ,2
years versus $2 years of age failed to demonstrate a significant
difference in the incidence of late SCD with up to 25 years of
follow-up. Although it is possible that significant differences
may emerge with longer follow-up, these differences have yet
to be established.
Study limitations. The present population-based study of
patients undergoing operation for common congenital heart
defects since 1958 included only residents of Oregon. A small
number of patients have incomplete follow-up data because of
patient relocation or failure to respond to inquiries on status.
However, it is unlikely that catastrophic events would not have
been detected in light of the multiple methods of investigation
and 90% follow-up through 1996. Also, because of the obser-
vational study design, there are distinct limitations in defining
secondary risk factors for late SCD, such as the lack of
consistent objective data regarding measures of ventricular
function.
Classification of the exact cause of SCD may be compli-
cated by the coexistence of factors such as venous obstruction
and atrial flutter in a patient with a previous Mustard repair of
D-TGA. In the present study, the classification of presumed
arrhythmic death was made only in the absence of other
identifiable causes of SCD. Conversely, arrhythmias were
invariably present in patients who died of acute ventricular
failure or coronary embolism, although these arrhythmias were
interpreted as sequelae rather than causes of SCD.
Conclusions. 1) The risk of late SCD during long-term
follow-up is diverse among patients with heterogeneous forms
of congenital heart disease. For some, the risk is only slightly
higher than the general population; conversely, a much higher
risk is present for patients with other defects, such as AS or
D-TGA. 2) The risk of late SCD may be time dependent for
high risk defects, increasingly primarily $20 years after oper-
ation. Further follow-up will be required to determine whether
this risk is linear or exponential. 3) Most but not all SCD in
these patients is presumably due to arrhythmic causes. Future
studies should consider whether some late SCDs may be due to
circulatory rather than arrhythmic causes.
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